# Morphic Holding Inc. (MORF)

Source: https://www.quantisnow.com/company/MORF
Generated: 2026-11-10T08:31:38.918Z

- Ticker: MORF
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- Website: morphictx.com

## About

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and MORF-720 and MORF-627, which is in the preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß1 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is based in Waltham, Massachusetts.

## Latest MORF news and filings

- 2025-07-21 11:00 UTC [Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies](https://www.quantisnow.com/insight/omega-funds-closes-oversubscribed-647-million-fund-viii-to-invest-6126099)
- 2024-08-26 11:39 UTC [SEC Form 15-12G filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-morphic-holding-inc-5671296)
- 2024-08-21 20:36 UTC [SEC Form 4] [Director Edwards Martin returned 2,376 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-edwards-martin-returned-2376-shares-to-the-company-closing-5668061)
- 2024-08-20 23:12 UTC [SEC Form 4] [Director Slattery Joseph P returned 9,066 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-slattery-joseph-p-returned-9066-shares-to-the-company-5666965)
- 2024-08-20 23:11 UTC [SEC Form 4] [Director Nashat Amir closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-nashat-amir-closing-all-direct-ownership-in-the-company-5666963)
- 2024-08-20 23:10 UTC [SEC Form 4] [Director Springer Timothy A closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-springer-timothy-a-closing-all-direct-ownership-in-the-5666959)
- 2024-08-20 23:09 UTC [SEC Form 4] [President and CEO Tipirneni Praveen P. closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-tipirneni-praveen-p-closing-all-direct-ownership-5666957)
- 2024-08-20 23:07 UTC [SEC Form 4] [SEC Form 4 filed by Director Gray Susannah](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-gray-susannah-5666955)
- 2024-08-20 23:05 UTC [SEC Form 4] [Director Christensen Gustav returned 100,517 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-christensen-gustav-returned-100517-shares-to-the-company-closing-5666951)
- 2024-08-20 23:04 UTC [SEC Form 4] [SEC Form 4 filed by Director Bischofberger Norbert W](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bischofberger-norbert-w-5666949)
- 2024-08-20 23:02 UTC [SEC Form 4] [SEC Form 4 filed by CMO Cooper Simon Peter](https://www.quantisnow.com/insight/sec-form-4-filed-by-cmo-cooper-simon-peter-5666947)
- 2024-08-20 23:01 UTC [SEC Form 4] [General Counsel and Secretary Devaul William returned 19,587 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/general-counsel-and-secretary-devaul-william-returned-19587-shares-to-5666944)
- 2024-08-20 23:00 UTC [SEC Form 4] [PRESIDENT Rogers Bruce returned 149,883 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-rogers-bruce-returned-149883-shares-to-the-company-closing-5666941)
- 2024-08-20 22:59 UTC [SEC Form 4] [CFO and COO Schegerin Marc returned 37,907 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/cfo-and-coo-schegerin-marc-returned-37907-shares-to-the-5666935)
- 2024-08-20 22:58 UTC [SEC Form 4] [SVP Finance and CAO Farrell Robert E Jr returned 12,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/svp-finance-and-cao-farrell-robert-e-jr-returned-12000-5666932)
- 2024-08-16 20:27 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-morphic-holding-inc-5662965)
- 2024-08-16 20:25 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-morphic-holding-inc-5662954)
- 2024-08-16 20:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-morphic-holding-inc-5662947)
- 2024-08-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-morphic-holding-inc-5662939)
- 2024-08-16 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-morphic-holding-inc-5662931)
- 2024-08-16 20:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-morphic-holding-inc-5662919)
- 2024-08-16 20:14 UTC [SEC Form POSASR filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-morphic-holding-inc-5662835)
- 2024-08-16 20:11 UTC [SEC Form POSASR filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-morphic-holding-inc-5662813)
- 2024-08-16 20:07 UTC [SEC Form 8-K] [SEC Form 8-K filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-morphic-holding-inc-5662782)
- 2024-08-16 14:24 UTC [SEC Form 25-NSE filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-morphic-holding-inc-5662461)
- 2024-08-16 13:13 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-morphic-holding-inc-5662395)
- 2024-08-16 12:51 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphic-holding-inc-5662356)
- 2024-08-16 12:38 UTC [Mergers & Acquisitions] [Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease](https://www.quantisnow.com/insight/lilly-completes-acquisition-of-morphic-to-improve-outcomes-and-expand-5662351)
- 2024-08-12 13:40 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-morphic-holding-inc-5654389)
- 2024-08-07 23:04 UTC [SEC Form 4] [General Counsel and Secretary Devaul William gifted 4,000 shares, decreasing direct ownership by 17% to 19,587 units (SEC Form 4)](https://www.quantisnow.com/insight/general-counsel-and-secretary-devaul-william-gifted-4000-shares-decreasing-5648570)
- 2024-08-07 11:47 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-morphic-holding-inc-5646458)
- 2024-08-05 21:15 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-morphic-holding-inc-5642965)
- 2024-08-05 21:04 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphic-holding-inc-5642907)
- 2024-08-02 23:10 UTC [SEC Form 4] [SVP Finance and CAO Farrell Robert E Jr gifted 2,000 shares, decreasing direct ownership by 15% to 11,781 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-finance-and-cao-farrell-robert-e-jr-gifted-2000-5641002)
- 2024-08-01 10:24 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-morphic-holding-inc-5636602)
- 2024-08-01 10:07 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphic-holding-inc-5636558)
- 2024-07-25 11:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-morphic-holding-inc-5626919)
- 2024-07-22 12:30 UTC [Market Chatter] [Stifel Maintains Hold on Morphic Holding, Raises Price Target to $57](https://www.quantisnow.com/insight/stifel-maintains-hold-on-morphic-holding-raises-price-target-to-5619074)
- 2024-07-19 10:26 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-morphic-holding-inc-5616691)
- 2024-07-19 10:09 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by Morphic Holding Inc.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-morphic-holding-inc-5616672)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MORF
- Earnings history: https://www.quantisnow.com/earnings/MORF
- Dividend history: https://www.quantisnow.com/dividends/MORF
- Insider transactions: https://www.quantisnow.com/insiders/MORF
- Options chain: https://www.quantisnow.com/options/MORF
- SEC 8-K filings only: https://www.quantisnow.com/company/MORF/8-k
- RSS and alerts for MORF: https://www.quantisnow.com/docs/rss-feeds.md